These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 29367582)

  • 1. Imaging of PDE2- and PDE3-Mediated cGMP-to-cAMP Cross-Talk in Cardiomyocytes.
    Pavlaki N; Nikolaev VO
    J Cardiovasc Dev Dis; 2018 Jan; 5(1):. PubMed ID: 29367582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential regulation of C-type natriuretic peptide-induced cGMP and functional responses by PDE2 and PDE3 in failing myocardium.
    Moltzau LR; Meier S; Aronsen JM; Afzal F; Sjaastad I; Skomedal T; Osnes JB; Levy FO; Qvigstad E
    Naunyn Schmiedebergs Arch Pharmacol; 2014 May; 387(5):407-17. PubMed ID: 24424715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphodiesterase-2 is up-regulated in human failing hearts and blunts β-adrenergic responses in cardiomyocytes.
    Mehel H; Emons J; Vettel C; Wittköpper K; Seppelt D; Dewenter M; Lutz S; Sossalla S; Maier LS; Lechêne P; Leroy J; Lefebvre F; Varin A; Eschenhagen T; Nattel S; Dobrev D; Zimmermann WH; Nikolaev VO; Vandecasteele G; Fischmeister R; El-Armouche A
    J Am Coll Cardiol; 2013 Oct; 62(17):1596-606. PubMed ID: 23810893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic Implications for PDE2 and cGMP/cAMP Mediated Crosstalk in Cardiovascular Diseases.
    Sadek MS; Cachorro E; El-Armouche A; Kämmerer S
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33050419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclic nucleotide hydrolysis in bovine aortic endothelial cells in culture: differential regulation in cobblestone and spindle phenotypes.
    Keravis T; Komas N; Lugnier C
    J Vasc Res; 2000; 37(4):235-49. PubMed ID: 10965223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PDE2 at the crossway between cAMP and cGMP signalling in the heart.
    Weber S; Zeller M; Guan K; Wunder F; Wagner M; El-Armouche A
    Cell Signal; 2017 Oct; 38():76-84. PubMed ID: 28668721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclic nucleotide phosphodiesterases in heart and vessels: A therapeutic perspective.
    Bobin P; Belacel-Ouari M; Bedioune I; Zhang L; Leroy J; Leblais V; Fischmeister R; Vandecasteele G
    Arch Cardiovasc Dis; 2016; 109(6-7):431-43. PubMed ID: 27184830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclic nucleotide phosphodiesterase-mediated integration of cGMP and cAMP signaling in cells of the cardiovascular system.
    Maurice DH
    Front Biosci; 2005 May; 10():1221-8. PubMed ID: 15769620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanodomain Regulation of Cardiac Cyclic Nucleotide Signaling by Phosphodiesterases.
    Kokkonen K; Kass DA
    Annu Rev Pharmacol Toxicol; 2017 Jan; 57():455-479. PubMed ID: 27732797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. cGMP signals modulate cAMP levels in a compartment-specific manner to regulate catecholamine-dependent signaling in cardiac myocytes.
    Stangherlin A; Gesellchen F; Zoccarato A; Terrin A; Fields LA; Berrera M; Surdo NC; Craig MA; Smith G; Hamilton G; Zaccolo M
    Circ Res; 2011 Apr; 108(8):929-39. PubMed ID: 21330599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microdomain switch of cGMP-regulated phosphodiesterases leads to ANP-induced augmentation of β-adrenoceptor-stimulated contractility in early cardiac hypertrophy.
    Perera RK; Sprenger JU; Steinbrecher JH; Hübscher D; Lehnart SE; Abesser M; Schuh K; El-Armouche A; Nikolaev VO
    Circ Res; 2015 Apr; 116(8):1304-11. PubMed ID: 25688144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclic nucleotide imaging and cardiovascular disease.
    Berisha F; Nikolaev VO
    Pharmacol Ther; 2017 Jul; 175():107-115. PubMed ID: 28216026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances, Perspectives and Potential Engineering Strategies of Light-Gated Phosphodiesterases for Optogenetic Applications.
    Tian Y; Yang S; Gao S
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33066112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. β
    Schobesberger S; Wright PT; Poulet C; Sanchez Alonso Mardones JL; Mansfield C; Friebe A; Harding SE; Balligand JL; Nikolaev VO; Gorelik J
    Elife; 2020 Mar; 9():. PubMed ID: 32228862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PDE3 inhibition by C-type natriuretic peptide-induced cGMP enhances cAMP-mediated signaling in both non-failing and failing hearts.
    Meier S; Andressen KW; Aronsen JM; Sjaastad I; Hougen K; Skomedal T; Osnes JB; Qvigstad E; Levy FO; Moltzau LR
    Eur J Pharmacol; 2017 Oct; 812():174-183. PubMed ID: 28697992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross talk between NO and cyclic nucleotide phosphodiesterases in the modulation of signal transduction in blood vessel.
    Lugnier C; Keravis T; Eckly-Michel A
    J Physiol Pharmacol; 1999 Dec; 50(4):639-52. PubMed ID: 10639014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cyclic nucleotide phosphodiesterases: role in the heart and therapeutic perspectives].
    Bedioune I; Bobin P; Karam S; Lindner M; Mika D; Lechêne P; Leroy J; Fischmeister R; Vandecasteele G
    Biol Aujourdhui; 2016; 210(3):127-138. PubMed ID: 27813474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of type 5 phosphodiesterase counteracts β2-adrenergic signalling in beating cardiomyocytes.
    Isidori AM; Cornacchione M; Barbagallo F; Di Grazia A; Barrios F; Fassina L; Monaco L; Giannetta E; Gianfrilli D; Garofalo S; Zhang X; Chen X; Xiang YK; Lenzi A; Pellegrini M; Naro F
    Cardiovasc Res; 2015 Jun; 106(3):408-20. PubMed ID: 25852085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclic nucleotide phosphodiesterases (PDEs) in human osteoblastic cells; the effect of PDE inhibition on cAMP accumulation.
    Ahlström M; Pekkinen M; Huttunen M; Lamberg-Allardt C
    Cell Mol Biol Lett; 2005; 10(2):305-19. PubMed ID: 16010295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential regulation of human platelet responses by cGMP inhibited and stimulated cAMP phosphodiesterases.
    Manns JM; Brenna KJ; Colman RW; Sheth SB
    Thromb Haemost; 2002 May; 87(5):873-9. PubMed ID: 12038792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.